SILVER2023

Doctors for Drug Policy Reform

Promoting Public Health in a Just Society

Washington, DC   |  d4dpr.org
GuideStar Charity Check

Doctors for Drug Policy Reform

EIN: 47-5335200


Mission

We are a global voice for licensed health professionals and scientists advocating for evidence-based drug policies and best practices that advance public health, reduce stigma, and minimize harm. We seek to leverage the expertise, compassion, and influence of licensed health professionals and scientists to enact changes in drug policy necessary to improve public health, human rights, social justice, and consumer protections.

Ruling year info

2016

President

Dr. Bryon Adinoff

Main address

712 H Street NE Suite 1290

Washington, DC 20002 USA

Show more contact info

EIN

47-5335200

Subject area info

Public safety

Public policy

Human rights

Public affairs

Population served info

People of African descent

People of Latin American descent

Low-income people

Incarcerated people

People with diseases and illnesses

NTEE code info

Public, Society Benefit - Multipurpose and Other N.E.C. (W99)

IRS subsection

501(c)(3) Public Charity

IRS filing requirement

This organization is required to file an IRS Form 990-N.

Tax forms

Communication

Blog

Programs and results

What we aim to solve

This profile needs more info.

If it is your nonprofit, add a problem overview.

Login and update

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Safe Labeling

David Nathan has developed the International Intoxicating Cannabis Product Symbol (IICPS). ASTM International has approved and published specifications of the IICPS, making it the only cannabis product symbol to bear the designation of an internationally recognized consensus standard (ASTM D8441). Several states have adopted the IICPS including Montana, Vermont, and New Jersey.

Population(s) Served

In 2022, D4DPR began offering a series of educational events:
Webinars are open to members and the public and focus on a range of relevant topics.
Ask the Expert are intimate group meetings where our most committed members can have candid, open, honest conversations on controversial or difficult topics led by a DFCR subject matter expert.

2022 Webinars:
Standardized Cannabis Labeling
Cannabis and the Opioid Crisis
Brittney Griner’s Imprisonment: Panel
Joint D4DPR/Marijuana Matters Webinar: Cannabis and Women's Health
Joint D4DPR/Parabola Center Webinar: Biden's Pardon & Call for Rescheduling

2022 Ask the Experts:
Cannabis use in pregnancy
Medical cannabis in the care of older adults
Cannabis in the treatment of cancer

Population(s) Served

Where we work

Affiliations & memberships

Marijuana Justice Coalition, Drug Policy Alliance 2021

Financials

Doctors for Drug Policy Reform
Fiscal year: Jan 01 - Dec 31

Revenue vs. expenses:  breakdown

SOURCE: IRS Form 990 info
NET GAIN/LOSS:    in 
Note: When component data are not available, the graph displays the total Revenue and/or Expense values.

Financial data

SOURCE: IRS Form 990

Doctors for Drug Policy Reform

Revenue & expenses

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

Fiscal year ending: cloud_download Download Data

Doctors for Drug Policy Reform

Balance sheet

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.

Fiscal year ending: cloud_download Download Data

Operations

The people, governance practices, and partners that make the organization tick.

President

Dr. Bryon Adinoff

Bryon Adinoff MD is an addiction psychiatrist and academician. Presently a Clinical Professor at the University of Colorado Anschutz Medical Campus, he retired in 2018 as the Distinguished Professor of Alcohol and Drug Abuse Research at the University of Texas Southwestern Medical Center and as a psychiatrist for 30 years with the Veterans Affairs. Dr. Adinoff has published more than 200 articles, reviews, and book chapters on the biology and treatment of addiction and is the Editor of The American Journal of Drug and Alcohol Abuse. He is a Distinguished Fellow in the American Academy of Addiction Psychiatry and the American Psychiatric Association. In his semi-retired status, he has become increasingly involved in advancing drug policy reform. In this capacity, he is President of Doctors for Drug Policy Reform, on the advisory board of SPORE (Society for Psychedelic Outreach, Reform and Education), and on the Drug Policy Alliances Marijuana Justice Coalition.

Doctors for Drug Policy Reform

Officers, directors, trustees, and key employees

SOURCE: IRS Form 990

Compensation
Other
Related
Show data for fiscal year
Compensation data
Download up to 5 most recent years of officer and director compensation data for this organization

There are no highest paid employees recorded for this organization.

This organization has no recorded board members.

Organizational demographics

SOURCE: Self-reported; last updated 2/7/2022

Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.

Leadership

No data

Race & ethnicity

Gender identity

Transgender Identity

Sexual orientation

No data

Disability

No data